Search Database

Select Protein (1 found)

UniProt ID Gene Symbol Protein Name Organism Length Action
Q9NWQ8 PAG1; CBP; PAG Phosphoprotein associated with glycosphingolipid-enriched microdomains … Homo sapiens (Human) 432 aa

Protein Details: Q9NWQ8 (PAG1)

Protein Information
Accession Q9NWQ8
Protein Names Phosphoprotein associated with glycosphingolipid-enriched microdomains 1 (Csk-binding protein) (Transmembrane adapter protein PAG) (Transmembrane phosphoprotein Cbp)
Gene Symbol PAG1; CBP; PAG
Organism Homo sapiens (Human)
Length 432 aa
Isoforms No isoforms
Related PMIDs 19801377 25914232 26111759 31251020 31382980 32651440
Database Sources dbPTM
These studies detected palmitoylation of this protein in the samples.
Tissue/Cell Line Expression
Tissue Specificity Index (TSI): 0.600
Bubble Size: Positive Samples Count Color Intensity: Positive Ratio
24
LNCaP cells
Specificity: 0.600
24/46 (52.2%)
7
Jurkat T cells
Specificity: 0.175
7/25 (28.0%)
3
T cells
Specificity: 0.075
3/4 (75.0%)
3
CEMx174 cells
Specificity: 0.075
3/3 (100.0%)
2
DU145 cells
Specificity: 0.050
2/2 (100.0%)
1
U937 cells
Specificity: 0.025
1/1 (100.0%)
0
HeLa cells
Specificity: 0.000
0/1 (0.0%)
0
PC3 cells
Specificity: 0.000
0/4 (0.0%)
0
HAP1 cells
Specificity: 0.000
0/10 (0.0%)
0
293T cells
Specificity: 0.000
0/10 (0.0%)
0
Endothelial cells
Specificity: 0.000
0/2 (0.0%)
0
Prefrontal cortex
Specificity: 0.000
0/1 (0.0%)
0
Cerebral cortex
Specificity: 0.000
0/4 (0.0%)
0
Liver membrane
Specificity: 0.000
0/1 (0.0%)
Palmitoylation Distribution by Study and Tissue/Cell Line
Chart Explanation: Each bar represents a study (PMID). The colored bottom segment shows palmitoylated samples, while the gray top segment shows non-palmitoylated samples. Bars are grouped by tissue/cell line for easy comparison.
Protein Sequence
Single Types:
Experimental Database High Prediction Medium Prediction Low Prediction
Combined Types:
All Three Exp + DB Exp + High Pred Exp + Med Pred Exp + Low Pred DB + High Pred DB + Med Pred DB + Low Pred Cysteine
1-501MGPAGSLLGS11GQMQITLWGS21LAAVAIFFVI31TFLIFLCSSC41DREKKPRQHS
51-10051GDHENLMNVP61SDKEMFSRSV71TSLATDAPAS81SEQNGALTNG91DILSEDSTLT
101-150101CMQHYEEVQT111SASDLLDSQD121STGKPKCHQS131RELPRIPPES141AVDTMLTARS
151-200151VDGDQGLGME161GPYEVLKDSS171SQENMVEDCL181YETVKEIKEV191AAAAHLEKGH
201-250201SGKAKSTSAS211KELPGPQTEG221KAEFAEYASV231DRNKKCRQSV241NVESILGNSC
251-300251DPEEEAPPPV261PVKLLDENEN271LQEKEGGEAE281ESATDTTSET291NKRFSSLSYK
301-350301SREEDPTLTE311EEISAMYSSV321NKPGQLVNKS331GQSLTVPEST341YTSIQGDPQR
351-400351SPSSCNDLYA361TVKDFEKTPN371STLPPAGRPS381EEPEPDYEAI391QTLNREEEKA
401-432401TLGTNGHHGL411VPKENDYESI421SDLQQGRDIT431RL
Palmitoylation Sites Details
Position Sources Domains Experimental PMIDs
37 DBPTM Prediction (High) Phosphoprotein associated with glycosphingolipid-enriched -
40 DBPTM Prediction (Medium) Phosphoprotein associated with glycosphingolipid-enriched -
Conservation Scores
PhyloP
PhastCons
TCGA Cysteine Mutation Information

Note: Mutations indicate amino acid changes that may create potential palmitoylation sites.

Position Amino Acid Change Frequency Type Function Cancer Type
179 C → C 0.001887 SNP Silent UCEC
237 R → C 0.002506 SNP Missense Mutation COAD
341 Y → C 0.002294 SNP Missense Mutation OV